NEWS & BLOGS

Clarification on Cell Immunotherapy in the EU and Key Immunotherapy Approaches
Due to some misinformation circulating in the field of Cell Immunotherapy, we would like to clarify a few important points. In the European Union (EU),

Innovita Group’s Technological Milestone in Dendritic Cell Vaccine (DCV) Production
Innovita is at the forefront of Medical Innovation with a significant breakthrough in cancer treatment protocols. Our latest advancement involves the enhancement of Dendritic Cell
Latest Posts

Clarification on Cell Immunotherapy in the EU and Key Immunotherapy Approaches
Due to some misinformation circulating in the field of Cell Immunotherapy, we would like to clarify a few important points. In the European Union (EU),

Innovita Group’s Technological Milestone in Dendritic Cell Vaccine (DCV) Production
Innovita is at the forefront of Medical Innovation with a significant breakthrough in cancer treatment protocols. Our latest advancement involves the enhancement of Dendritic Cell

Link between chemotherapy and cancer metastases
A recent article, “Potential New Treatment Improving Chemotherapy Efficacy and Reducing Metastasis Discovered” published in Inside Precision Medicine has outlined an important discovery with regards